[1] |
LI Lei, LIU Xiaodan, ZHOU Kaixiang, HE Linjie, ZHANG Jian, CHEN Qiang, MENG Han, FENG Huan, ZHANG Wenming, LU Jun, ZHOU Feng, CUI Hongzun, NIU Wancheng, ZHANG Zhaohui.
Effects of ischemia postconditioning on mitochondrial function in rats and its protective mechanisms in hepatic ischemia-reperfusion injury
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 48-54.
|
[2] |
YANG Jun, KANG Wei, ZHONG Wuning, ZHAO Xin.
Predictive value of radiomics model based on cone-beam breast CT images for pathological complete response of neoadjuvant therapy in breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 103-108.
|
[3] |
ZHANG Xiaomeng, WANG Yue, WAN Qiaoqin.
Summary of evidence for the management of drug-related symptoms during endocrine therapy in breast cancer patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 615-621.
|
[4] |
ZHANG Yening, PANG Ying, HE Yi, TANG Lili.
Status quo and reflections on psychological pain and psychotherapy in patients with advanced breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 622-628.
|
[5] |
LI Tingting, LIU Yan .
Comparison of the separation and purification methods of small extracellular vesicles in mesenchymal stem cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 424-432.
|
[6] |
XIE Changquan, HE Fengyi, LU Guodong, LI Qiuyun.
Andrographolide combined with doxorubicin induces cell death in breast cancer cell via ROS-dependent DNA damage
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 302-307.
|
[7] |
WU Hualing, LIN Qing .
Analysis of clinical and dosimetric factors related to radiation pneumonitis after intensity-modulated radiotherapy in breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 327-331.
|
[8] |
LUO Xianting, FENG Yimin, ZHOU Jing, XIAO Lei, YIN Jiayu, ZHAO Xin, SU Danke.
Value of Kaiser score-based MRI feature nomogram model in preoperative prediction of vascular invasion in mass breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 332-338.
|
[9] |
LEI Sen, WANG Hongxue, WANG Han, TAN Aihua, YANG Huawei, XIE Weimin.
Research progress of anti-HER2 targeted drugs in the treatment of breast cancer with brain metastases
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 367-374.
|
[10] |
WANG Rong, ZHOU Zhihui, LI Hong, LI Zihui.
A study on the mechanism of Bufotalin-induced ferroptosis in acute promyelocytic leukemia HL-60 cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 158-165.
|
[11] |
LEI Lei, XUE Xiaojing, SHI Qiulin, WANG Xiaoyan, FENG Gang, YANG Lijuan, JIANG Yuan, LIU Ran.
Summary of the best evidence for non?drug prevention and management of sleep disorders in breast cancer survivors
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 223-229.
|
[12] |
WANG Yong, ZHOU Yuling, ZHOU Qionghui, ZENG Biao, HU Ying.
Application of 3D printing compensation film in postoperation radiotherapy of immediate breast reconstruction for breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 96-100.
|
[13] |
GAO Fangfang, CHEN Binjie, TAN Qixing, HUANG Zhen, LU Weifeng, WEI Changyuan.
Analysis of risk factors of prognosis,recurrence and metastasis of breast cancer patients with non-pathologic complete response after neoadjuvant chemotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 650-656.
|
[14] |
MA Liangliang, SUN Lichao.
The novel strategy for breast cancer treatment based on mitochondrial abnormalities: mitochondrial transplantation
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 667-671.
|
[15] |
LI Tingting, LIU Yan.
Relationship between mesenchymal stem cells and cancer stem cells in tumor microenvironment and their role in breast cancer progression
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 684-689.
|